Step 1 · Draw volume
draw volume (mL) = dose (mg) ÷ concentration (mg/mL)
This equation does not establish the dose; it only converts a confirmed amount. Doses are often stated in mcg: 1 mg = 1,000 mcg. Convert before dividing.
Updated September 2026 · Research reference only
This peptide dosage chart compiles commonly referenced research dosage ranges for popular peptides. Use it to understand the terms in a source you already have and to check concentration math. It does not choose a personal dose, schedule, product, or route. All dosages are for research reference only — consult a healthcare provider before using any peptide.
Starting points, not recommendations — set your own dose with a clinician. Research reference only.
| Peptide | Typical research dose range | Frequency | Route |
|---|---|---|---|
| Healing & Recovery | |||
| BPC-157 | 200–500 mcg | Daily | SubQ / oral |
| TB-500 | 2.5–5 mg | Twice weekly | SubQ |
| Thymosin Alpha-1 | 0.8–1.6 mg | Twice weekly | SubQ |
| LL-37 | 0.5–1 mg | Daily | SubQ |
| PEG-MGF | 100–200 mcg | Daily | IM / SubQ |
| Muscle & Performance | |||
| CJC-1295 | 1–2 mg | 2–3× weekly | SubQ |
| Ipamorelin | 200–300 mcg | 2–3× daily | SubQ |
| Sermorelin | 200–500 mcg | Daily | SubQ |
| GHRP-2 | 100–300 mcg | 1–3× daily | SubQ |
| GHRP-6 | 100–300 mcg | 1–3× daily | SubQ |
| Hexarelin | 100–200 mcg | Daily | SubQ |
| Tesamorelin | 1–2 mg | Daily | SubQ |
| IGF-1 LR3 | 20–60 mcg | Daily | SubQ / IM |
| HGH Fragment 176-191 | 250–500 mcg | Daily | SubQ |
| Skin & Longevity / Metabolic | |||
| AOD 9604 | 300–500 mcg | Daily | SubQ |
| GHK-Cu | 1–2 mg | Daily | Topical / SubQ |
| Epitalon | 5–10 mg | Daily | SubQ |
| Melanotan II | 250–500 mcg | Varies by study | SubQ |
| PT-141 | 0.75–1.75 mg | As needed in studies | SubQ |
| MOTS-c | 5–10 mg | 2–3× weekly | SubQ |
| DSIP | 100–300 mcg | Evening schedules vary | SubQ |
| Selank | 250–750 mcg | Daily | Intranasal / SubQ |
| Semax | 200–600 mcg | Daily | Intranasal |
| Kisspeptin | 50–200 mcg | 1–2× daily | SubQ |
| Cerebrolysin (peptide complex) | 10–50 mL | Daily study courses | IM / IV |
| NAD+ (not a peptide) | 50–100 mg | 2–3× weekly | SubQ / IV |
SubQ = subcutaneous; IM = intramuscular; IV = intravenous. Source-type labels: Supp. docs = supplier documentation; Clinical = published clinical study; Animal / Preclinical = non-human data only. Route labels describe cited source context, not administration instructions.
GLP-1 metabolic medicines use labelled titration schedules. The entries below point to official information; they are not a personal prescription. Never begin at a target dose.
| Medicine | Start → target in label or trial | Source |
|---|---|---|
| Semaglutide | 0.25 → 2.4 mg weekly | FDA label |
| Tirzepatide | 2.5 → 15 mg weekly | FDA label |
| Cagrilintide | 0.3 → 4.5 mg weekly in trials | Clinical trial registry; not FDA-approved |
The arithmetic is simple once the inputs are confirmed. First translate a documented mass into a concentration; then translate a separately confirmed amount into a liquid draw volume. A syringe scale is the last conversion step, not a substitute for knowing concentration.
draw volume (mL) = dose (mg) ÷ concentration (mg/mL)
This equation does not establish the dose; it only converts a confirmed amount. Doses are often stated in mcg: 1 mg = 1,000 mcg. Convert before dividing.
syringe units = draw volume (mL) × 100
Use this only after confirming that the syringe packaging identifies it as U-100. Other calibrations use a different scale.
concentration (mg/mL) = vial amount (mg) ÷ confirmed final liquid volume (mL)
“Confirmed final liquid volume” is a documented input. This page does not select the liquid, volume, or preparation method.
Confirm the product, formulation, units, document version, vial amount, and final liquid volume. Make sure the vial label and source document match before entering a number.
Convert mg to mcg only when helpful: 1 mg equals 1,000 mcg. Do not use syringe markings as a mass unit. Write the unit beside every amount so the calculation stays readable.
Keep route, product form, stated conditions, and safety information with the original source rather than copying a number alone.
Concentration = mg ÷ mL
Draw volume = stated amount ÷ concentration
U-100 units = draw volume in mL × 100
5 mg in 2 mL = 2.5 mg/mL. A stated 0.5 mg amount = 0.2 mL = 20 U-100 units.
10 mg in 2 mL = 5 mg/mL. A stated 0.25 mg amount = 0.05 mL = 5 U-100 units.
5 mg in 1 mL = 5 mg/mL. A stated 0.5 mg amount = 0.1 mL = 10 U-100 units.
Use the numbers from your vial to calculate the matching mL and U-100 units.
Open the peptide dosage calculatorNo. This chart compiles commonly referenced research dose ranges and is a research reference only — not a prescription. Dose decisions belong to you and a clinician.
Ranges reflect commonly cited research contexts, not universal recommendations. Source-type labels (Supp. docs / Clinical / Animal) show where each figure comes from.
It depends on concentration. At 2.5 mg/mL, 500 mcg equals 0.2 mL, or 20 units on a U-100 syringe. Always confirm your own concentration first.
No. They are titrated from a low starting dose upward (for example, 0.25 mg weekly for semaglutide). Never begin at a target dose — see the FDA label section above.
The same peptide can appear with different routes across published research. Route labels describe cited source context only and are not administration instructions.
They come from publicly available research literature, product documentation, and FDA labels where applicable. See the Sources section below for the source types used on this page.
Primary clinical, pharmacology, and preclinical literature.
Trial context for investigational compounds.
Identity and formulation checks; supplier material is not clinical validation.
Disclaimer: For research purposes only. This guide is educational, not medical advice, dosing recommendations, or a default protocol. Follow your product documentation and verified protocol.